Team develops a rapid test to measure immunity to SARS-CoV-2

Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone's immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population's ...

New chemical method advances toward targeted RNA medicine

Targeted drugs aim to pinpoint the exact location in the body where diseased tissue is located and where the medicine is required. The manifold benefits of administering a targeted drug include heightened efficacy, as the ...

Exploring the limits of a new kind of chemo

Chemotherapy sucks. The treatments generally have awful side effects, and it's no secret that the drugs involved are often toxic to the patient as well as their cancer. The idea is that, since cancers grow so quickly, chemotherapy ...

The use of magnetic nanoparticles for cancer therapy

A joint research paper from Chemnitz University of Technology and Shivaji University (India) titled "APTES monolayer coverage on self-assembled magnetic nanospheres for controlled release of anticancer drug Nintedanib" was ...

page 31 from 40